BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.


Thought Leadership

Transforming Trials

ICON is rethinking the clinical trials process using new approaches, coupled with existing technologies to substantially reduce the risk and cost of clinical drug development.

Adaptive Trials

Insights to help you understand and address the complexities of adaptive trial design and execution. 

Wearables

Understand and successfully address the complexities of implementation of wearable devices in trial design, execution and reporting.

Global Outcomes Benchmarking

ICON and ICHOM working to develop risk-adjusted, international benchmarks on health outcomes by medical condition.

Meeting Evidentiary Needs with Electronic Health Records

Read this white paper to learn how you can leverage these systems for maximum benefit in observational studies and pragmatic clinical trials. 

Harnessing Technology to maximise RWE value

Technology innovations can enable faster collection, standardisation, and analysis of real world data assets. Learn how sponsors can take full advantage of these innovations.

Transforming medical device development with mHealth

How are mHealth technologies combining trial efficiency and patient care into the latest medical devices? Learn more in our white paper.

Cardiovascular Medical Devices

Discover how sponsors can respond to new business risks and opportunities in a value-based payment environment with this white paper. 

MDR and IVDR are Coming - Are you Prepared?

Discover the best methods for mitigating anticipated delays and increased costs in this new regulatory environment.

Bring Your Own Device (BYOD)

BYOD promises greater patient-centricity and will make study management less complex.

Transforming Medical Device Development

ICON whitepaper which deconstructs the critical challenges to achieving mandates for cost efficiency and productivity.

Strategic Alliances

ICON sponsored research outlines partnership strategies to optimise clinical drug development.

ICH GCP (R2)

The upcoming addendum focuses on three key areas; technology validation and certification, risk based quality management systems and increased oversight.

Adaptive Design: The Faster Path to Market

An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.

Setting the Scene in Immuno-Oncology

Look to the future of immuno-oncology, and foresee emerging challenges in drug development as well as growing treatment options in our complimentary white paper.